Variations in the estimated intake of acrylamide from food in the Japanese population.


Journal

Nutrition journal
ISSN: 1475-2891
Titre abrégé: Nutr J
Pays: England
ID NLM: 101152213

Informations de publication

Date de publication:
21 02 2020
Historique:
received: 17 10 2019
accepted: 17 02 2020
entrez: 23 2 2020
pubmed: 23 2 2020
medline: 11 3 2021
Statut: epublish

Résumé

Due to concerns of carcinogenicity, it is necessary to assess long-term acrylamide exposure in individuals. Whether the available methods of estimating acrylamide intake can indicate long-term exposure remains unknown. We examined variations in the estimated dietary acrylamide intake of the Japanese population. The study included 240 participants aged 40-74 years who were a part of the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT). Twelve-day dietary records (DRs) were collected over a one-year period, and food frequency questionnaires (FFQs) were collected twice during the year. Dietary acrylamide intake was estimated from an acrylamide content database. Within-individual variations and between-individual variations were calculated using the random effects model. A linear regression analysis was performed to identify foods with large between-individual variations. The ratios of within-individual variance to between-individual variation were 3.2 for men and 4.3 for women. Days of DRs required to estimate the usual individual intake within 20% of the true mean intake with 95% confidence were 60 days for men and 66 days for women. Coffee/cocoa, potato, and green tea contributed to between-individual variations, in that order, and seven foods contributed to 93% of the between-individual variation. Estimating the acrylamide intake using DRs requires an extended data collection period to estimate the intragroup ranking and habitual intake of individuals. Long-term exposure assessments should be based on methods with less potential for measurement errors, such as the use of biomarkers.

Sections du résumé

BACKGROUND
Due to concerns of carcinogenicity, it is necessary to assess long-term acrylamide exposure in individuals. Whether the available methods of estimating acrylamide intake can indicate long-term exposure remains unknown. We examined variations in the estimated dietary acrylamide intake of the Japanese population.
METHODS
The study included 240 participants aged 40-74 years who were a part of the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT). Twelve-day dietary records (DRs) were collected over a one-year period, and food frequency questionnaires (FFQs) were collected twice during the year. Dietary acrylamide intake was estimated from an acrylamide content database. Within-individual variations and between-individual variations were calculated using the random effects model. A linear regression analysis was performed to identify foods with large between-individual variations.
RESULTS
The ratios of within-individual variance to between-individual variation were 3.2 for men and 4.3 for women. Days of DRs required to estimate the usual individual intake within 20% of the true mean intake with 95% confidence were 60 days for men and 66 days for women. Coffee/cocoa, potato, and green tea contributed to between-individual variations, in that order, and seven foods contributed to 93% of the between-individual variation.
CONCLUSIONS
Estimating the acrylamide intake using DRs requires an extended data collection period to estimate the intragroup ranking and habitual intake of individuals. Long-term exposure assessments should be based on methods with less potential for measurement errors, such as the use of biomarkers.

Identifiants

pubmed: 32085713
doi: 10.1186/s12937-020-00534-y
pii: 10.1186/s12937-020-00534-y
pmc: PMC7035741
doi:

Substances chimiques

Acrylamide 20R035KLCI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17

Références

J Agric Food Chem. 2006 Sep 20;54(19):7370-7
pubmed: 16968107
Eur J Clin Nutr. 2010 May;64(5):534-40
pubmed: 20234383
J Nutr Sci Vitaminol (Tokyo). 2018;64(5):340-346
pubmed: 30381624
Food Chem Toxicol. 2000 Apr;38(4):371-83
pubmed: 10722891
J Epidemiol. 2013;23(3):178-86
pubmed: 23583922
Eur J Clin Nutr. 1999 Oct;53(10):781-5
pubmed: 10556984
Food Chem Toxicol. 2012 Mar;50(3-4):889-94
pubmed: 22240413
Shokuhin Eiseigaku Zasshi. 2004 Feb;45(1):44-8
pubmed: 15168561
J Epidemiol. 2002 Mar;12(2):85-92
pubmed: 12033533
Eur J Nutr. 2013 Jun;52(4):1369-80
pubmed: 23238529
Eur J Nutr. 2013 Aug;52(5):1503-12
pubmed: 23114503
Food Chem Toxicol. 2016 Jan;87:97-102
pubmed: 26607107
J Agric Food Chem. 2002 Aug 14;50(17):4998-5006
pubmed: 12166997
Food Chem Toxicol. 2012 Jul;50(7):2531-9
pubmed: 22525869
J Epidemiol. 2018 Dec 5;28(12):482-487
pubmed: 29806636
Public Health Nutr. 2005 Dec;8(8):1293-9
pubmed: 16372925
J Epidemiol. 2016 Aug 5;26(8):420-32
pubmed: 27064130
Eur J Clin Nutr. 2004 Dec;58(12):1604-11
pubmed: 15199383
Int J Cancer. 2015 Jun 15;136(12):2912-22
pubmed: 25403648
Cancer Sci. 2018 Mar;109(3):843-853
pubmed: 29288560

Auteurs

Kumiko Kito (K)

Graduate School of Environmental Health, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara-city, Kanagawa, 252-5201, Japan.

Junko Ishihara (J)

Department of Food and Life Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara-city, Kanagawa, 252-5201, Japan. j-ishihara@azabu-u.ac.jp.

Junpei Yamamoto (J)

Department of Food and Life Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara-city, Kanagawa, 252-5201, Japan.

Takayuki Hosoda (T)

Department of Food and Life Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara-city, Kanagawa, 252-5201, Japan.

Ayaka Kotemori (A)

Department of Food and Life Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara-city, Kanagawa, 252-5201, Japan.

Ribeka Takachi (R)

Department of Food Science and Nutrition, Nara Women's University Graduate School of Humanities and Sciences, Kitauoyahigashimachi Nara-shi, Nara, 630-8506, Japan.

Kazutoshi Nakamura (K)

Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Niigata, 951-8510, Japan.

Junta Tanaka (J)

Department of Health Promotion Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Niigata, 951-8510, Japan.

Taiki Yamaji (T)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Taichi Shimazu (T)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Yuri Ishii (Y)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Norie Sawada (N)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Motoki Iwasaki (M)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Hiroyasu Iso (H)

Public Health, Department of Social Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita-city, Osaka, 565-0871, Japan.

Tomotaka Sobue (T)

Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita-city, Osaka, 565-0871, Japan.

Shoichiro Tsugane (S)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH